Corbus Pharmaceuticals Holdings Inc. (CRBP) Live Share Price, Invest From India

Corbus Pharmaceuticals Holdings Inc. Stock Performance

as on July 24, 2026 at 6:59 am IST

Day's Low
Day's High
$8.73
Day's Price Range
$9.47
$9.33
6.43%
Downside
1.50%
Upside
52 Week's Low
52 Week's High
$7.12
52-Week Price Range
$20.56
$9.33
23.69%
Downside
120.36%
Upside

Corbus Pharmaceuticals Holdings Inc. share price movements today

Previous Close: $8.84
Open: $8.80
Volume: 1.1M
Day's Low - High: $8.73 - $9.47
52 Week Low - High: $7.12 - $20.56

Corbus Pharmaceuticals Holdings Inc. Historical Returns

1 Month Return: + 8.13 %
3 Month Return: -12.13 %
1 Year Return: -1.89 %
3 Year Return: + 35.79 %
5 Year Return: -79.1 %

Corbus Pharmaceuticals Holdings Inc. Stock Fundamentals & Key Indicators

Check Corbus Pharmaceuticals Holdings Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$166.4M

EPS (TTM)

-4.565

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-89.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-66.70%

Corbus Pharmaceuticals Holdings Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals Holdings Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Corbus Pharmaceuticals Holdings Inc.	BUY	$166.4M	-79.1%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.0B	532.45%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	135.7%	28.49	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.8B	11.06%	16.42	29.65%	0.53%

Stock Returns calculator for Corbus Pharmaceuticals Holdings Inc. Stock including INR - Dollar returns

The Corbus Pharmaceuticals Holdings Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Corbus Pharmaceuticals Holdings Inc. investment value today

Current value as on today

₹1,15,770

Returns

₹15,770

(+15.77%)

Returns from Corbus Pharmaceuticals Holdings Inc. Stock

₹3,552 (+3.55%)

Dollar Impact

₹12,219 (+12.22%)

Analyst Recommendation on Corbus Pharmaceuticals Holdings Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals Holdings Inc.. Average target price of $35.3

Corbus Pharmaceuticals Holdings Inc. Share Price Target

Get share price movements and forecasts by analysts on Corbus Pharmaceuticals Holdings Inc..

What analysts predicted

73.57%UPSIDE

Target Price

$35.3

Current Price

$9.33

Analyzed by

8 Analysts

Target

$35.30

Corbus Pharmaceuticals Holdings Inc. target price $35.3, a slight upside of 73.57% compared to current price of $9.33. According to 8 analysts rating.

Indian Investors' Interest in Corbus Pharmaceuticals Holdings Inc. Stock

Search interest for Corbus Pharmaceuticals Holdings Inc. Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 24, 2026 to July 24, 2026

Change:-2% versus previous 30 day period

Corbus Pharmaceuticals Holdings Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	1	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	-15	0	-	0	0
Operating Income	-10	-9	-10	-15	-12	-19	-19	-24	-21	-24
EBITDA	-7	-5	-9	-13	-9	-18	-17	-23	-20	-22
Interest Expense	0	0	0	0	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-6	-9	-13	-9	-16	-17	-23	-20	-22
Income Tax Expense	0	0	-	-	-	-	-	-	-	-
Net Income	-8	-6	-9	-13	-9	-16	-17	-23	-20	-22
Net Profit Margin	-594.27%	0.00%	0.00%	0.00%	-1354.89%	0.00%	0.00%	0.00%	0.00%	0.00%

Corbus Pharmaceuticals Holdings Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	2	4	36	3	0	-	-	-	-
Gross Profit	-13	-23	-43	-53	3	0	-1	-31	0	0
Operating Income	-19	-32	-56	-77	-122	-55	-34	-45	-48	-85
EBITDA	-19	-32	-56	-76	-121	-42	-38	-40	-37	-78
Interest Expense	-	0	-	0	1	1	2	2	1	-
Depreciation	-	0	0	1	1	1	1	1	0	0
Income Before Tax	-19	-32	-55	-71	-111	-45	-42	-44	-40	-78
Income Tax Expense	0	0	1	-2	0	0	13	-	-	-
Net Income	-19	-32	-55	-71	-111	-45	-55	-44	-40	-78
Net Profit Margin	-1046.27%	-1328.65%	-1154.48%	-197.69%	-2826.08%	-5166.42%	0.00%	0.00%	0.00%	0.00%

Corbus Pharmaceuticals Holdings Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-6	-9	-13	-9	-16	-17	-23	-20	-22
Operating Cash Flow	-7	-8	-13	-10	-16	-16	-15	-15	-25
Investing Cash Flow	-98	-16	-15	8	18	17	19	-57	22
Financing Cash Flow	106	34	25	0	-	-	2	74	-
Change in Cash	0	9	-4	-2	1	1	6	1	-3

Corbus Pharmaceuticals Holdings Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-32	-55	-71	-111	-45	-42	-44	-40	-78
Operating Cash Flow	-27	-30	-45	-99	-48	-37	-36	-41	-64
Investing Cash Flow	0	-2	-2	0	-73	30	35	-121	-1
Financing Cash Flow	76	11	38	154	60	0	-2	166	77
Change in Cash	47	-20	-9	54	-60	-8	-3	3	11

Global Institutional Holdings in Corbus Pharmaceuticals Holdings Inc.

Funds	Holdings
Aberdeen Group PLC	7.13%
Octagon Capital Advisors LP	5.38%
Vanguard Group Inc	4.64%
Vanguard Capital Management, LLC	3.96%
Citadel Advisors Llc	3.92%

See all

Insights on Corbus Pharmaceuticals Holdings Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 387.7% return, outperforming this stock by 387.1%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 583.7% return, outperforming this stock by 554.5%
NEGATIVE IMPACT
Price Dip
In the last 3 months, CRBP stock has moved down by -13.5%

About Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Organisation	Corbus Pharmaceuticals Holdings Inc.
Headquarters	500 River Ridge Drive, Norwood, MA, United States, 02062
Industry	Biotechnology
CEO	Dr. Yuval Cohen Ph.D.
E-voting on shares	Click here to vote

Key Management of Corbus Pharmaceuticals Holdings Inc.

Name	Title
Mr. Sean F. Moran CPA, M.B.A.	Chief Financial Officer
Dr. Ian Hodgson B.Sc., Ph.D.	Chief Operating Officer
Mr. G. Scott Goeken J.D., M.S.	General Counsel & Corporate Secretary
Ms. Christina Bertsch M.A.	Vice President of Human Resources
Mr. Nishant C. Saxena	Chief Business Officer
Dr. Leonardo Viana Nicacio M.D.	Chief Medical Officer
Dr. Yuval Cohen Ph.D.	CEO & Director

FAQs

What is Corbus Pharmaceuticals Holdings Inc. share price today?

Corbus Pharmaceuticals Holdings Inc. share price today is $9.33 as on July 24, 2026 at 1:29 am IST at the close of the market. Corbus Pharmaceuticals Holdings Inc. share today touched a day high of $9.47 and a low of $8.73.

What is the 52 week high and 52 week low for Corbus Pharmaceuticals Holdings Inc. share?

Corbus Pharmaceuticals Holdings Inc. share touched a 52 week high of $20.56 on October 20, 2025 and a 52 week low of $7.12 on June 2, 2026. Corbus Pharmaceuticals Holdings Inc. stock price today i.e. July 24, 2026 at 1:29 am IST is closed at $9.33,which is 54.62% down from its 52 week high and 31.04% up from its 52 week low.

What is Corbus Pharmaceuticals Holdings Inc.'s market capitalisation today?

Corbus Pharmaceuticals Holdings Inc. market capitalisation is $0.00T as on July 24, 2026 at 1:29 am IST.

How to invest in Corbus Pharmaceuticals Holdings Inc. Stock (CRBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Corbus Pharmaceuticals Holdings Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corbus Pharmaceuticals Holdings Inc. Shares that will get you 0.1608 shares as per Corbus Pharmaceuticals Holdings Inc. share price of $9.33 per share as on July 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Corbus Pharmaceuticals Holdings Inc. Stock (CRBP) from India?

Indian investors can start investing in Corbus Pharmaceuticals Holdings Inc. (CRBP) shares with as little as ₹96.5725 or $1 (as of July 24, 2026 at 1:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹965.73 in Corbus Pharmaceuticals Holdings Inc. stock (as per the Rupee-Dollar exchange rate as on July 24, 2026 at 1:37 am IST). Based on Corbus Pharmaceuticals Holdings Inc. share’s latest price of $9.33 as on July 24, 2026 at 1:29 am IST, you will get 1.0718 shares of Corbus Pharmaceuticals Holdings Inc.. Learn more about fractional shares .

What are the returns that Corbus Pharmaceuticals Holdings Inc. has given to Indian investors in the last 5 years?

Corbus Pharmaceuticals Holdings Inc. stock has given -79.1% share price returns and 29.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?